SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Armstrong, M A
Right arrow Articles by Hawkins, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, M A
Right arrow Articles by Hawkins, S A
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Relationship between tumour necrosis factor-alpha (TNF{alpha}) production and a specific multiple sclerosis (MS) associated TNF gene haplotype

M A Armstrong

Department of Microbiology & Immunobiology, The Queen's University of Belfast

G V McDonnell

Northern Ireland Regional Neurology Service, Royal Victoria Hospital, Belfast

C A Graham

Northern Ireland Regional Genetics Service, Belfast City Hospitals Trust, Belfast

C W Kirk

Northern Ireland Regional Genetics Service, Belfast City Hospitals Trust, Belfast

A G Droogan

Northern Ireland Regional Neurology Service, Royal Victoria Hospital, Belfast

S A Hawkins

Northern Ireland Regional Neurology Service, Royal Victoria Hospital, Belfast, School of Clinical Medicine, The Queen's University of Belfast, Belfast

Objective: To determine if monocyte TNFa production from patients homozygous for a specific MS associated TNF gene haplotype is different from that produced in patients either heterozygous for, or without this haplotype. Background: The balance between pro- and anti-inflammatory cytokines is important in the clinical outcome of inflammatory reactions. Levels of TNFa, a pro-inflammatory cytokine, is raised in MS as well as being found in acute and chronic MS lesions. A previous population based study in Northern Ireland with polymorphisms spanning the TNF gene region identified a conserved MS associated haplotype in relation to three markers (130: 118: 127 TNF d: a: b) for which 19 MS patients were homozygous. Methods: Venous blood collected in EDTA to give a concentration of 1073 M was drawn from 16 patients with the conserved MS associated haplotype, 19 patients heterozygous for the haplotype and 17 patients without the haplotype. Mononuclear cells were separated and cultured by standard techniques and levels of TNFa and of TNF binding proteins I and II were determined by commercial enzyme-linked immunosorbent assays. Results: There were no significant differences in TNFa production in the 3 h (P=0.28) or 24 h cultures (P=0.18) or following stimulation with interferon-g (P=0.17) between the group positive for the conserved haplotype and the group negative for this haplotype. There was also no significant difference when compared to the heterozygote group. No association was found between the MS associated haplotype and levels of either TNF binding protein. A greater proportion of patients with the conserved haplotype had a benign clinical course (P=0.06). Conclusion: We conclude that whilst a trend exists, we have found no significant association between peripheral TNFa production and a specific MS associated TNF haplotype in this population. Paradoxically this haplotype may also predict a more favourable clinical course.

Key Words: tumour necrosis factor-alpha • tumour necrosis factor receptors • monocytes • association studies • cytokines • multiple sclerosis

Multiple Sclerosis, Vol. 5, No. 3, 165-170 (1999)
DOI: 10.1177/135245859900500305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
L G Palacio, D Rivera, J J Builes, M E Jimenez, M Salgar, J M Anaya, I Jimenez, M Camargo, M Arcos-Burgos, and J L Sanchez
Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF
Multiple Sclerosis, June 1, 2002; 8(3): 249 - 255.
[Abstract] [PDF]



Advertisement